I've been on tysabri since 2006 and I am doing as well as can be expected. My physical demise has been slowed. There have been no more lesions. Don't know what you are talking about.
They are doing terrible, because, the synthetic interferon drugs, and the newer MS drugs DONT WORK. Biogen has spoofed the healthcare community for years about its MS panacea, made billions, on sketchy
waiting for European decision on protective status for a drug due out tomorrow according to (I think Wells Fargo) post I saw on Alpha.
Gazyva -- a potential blockbuster treatment for previously untreated chronic lymphocytic leukemia, or CLL -- was recently approved by the Food and Drug Administration, marking the company's fifth cancer treatment approval in the U.S. over the past three years. Gazyva was discovered by Roche's wholly owned subsidiary, Glycart. In the United States, the drug is part of a collaboration between its subsidiary Genentech and Biogen (NASDAQ: BIIB ) .
There is a lot of money to be made here...just watch the action day to day. Good company but a great stock
You're right, I see where it hit $262 for a second, but without a buyer it won't sell.